PubMed COVID-19 Clinical Care

INTRODUCTION: In order to study the impact of social factors on the evolution of the epidemic, this paper takes the COVID-19 in Hubei Province of China as an example to study the impact of social factors such as the permanent population, universities

CONCLUSIONS: The present study suggests that overall satisfaction with teleconsultations was high among patients and/or caregivers for telepsychiatry consultations.

CONCLUSIONS: There is little evidence to suggest there have been any major increases in epilepsy-related deaths in Scotland during the COVID-19 pandemic. COVID-19 is a common underlying cause of both epilepsy-related and unrelated deaths.

No abstract

Utilising a retrospective cohort study of SARS-CoV-2 wildtype (Wuhan) strain, we aimed to 1) utilise the unique Australian experience of temporarily eliminating SARS-CoV-2 to document and estimate the hospitalisation demand; and 2) estimate the

CONCLUSIONS: COVID-19 is an asymptomatic-mild disease in most young healthy children, with gradually diminishing emotional symptoms. Children without prolonged respiratory symptoms revealed no significant pulmonary sequelae as evaluated by EBC

To effectively mitigate the spread of communicable diseases, it is necessary to understand the interactions that enable disease transmission among individuals in a population; we refer to the set of these interactions as a contact network. The

SARS-CoV-2 can directly or indirectly damage endothelial cells. Endothelial injury, especially phosphatidylserine (PS) exposure on the outer membrane of cells, can more easily promote thrombosis. Type 2 diabetes(T2D) patients were more susceptible to

Most studies on the long-term effects of SARS-CoV-2 infection have been retrospective, have lacked an uninfected comparison group, and have focussed on the prevalence of individual symptoms, resulting in different estimates of prevalence. Recognizing

CONCLUSION: Given the ongoing strain and demand of COVID-19 on the healthcare system, a centralized, multi-disciplinary team of experts allowed for efficient delivery of COVID-19 therapies through one provider touchpoint. The collaboration between